“There is a significant need by pharmaceutical and medical products companies for business intelligence solutions that leverage vast stores of clinical data into actionable insights, decision models and measurable outcomes,” said Andrade. “DecisionView is an exciting opportunity that focuses squarely on software application solutions for improving performance across clinical operations of the global pharmaceutical and medical enterprise. I look forward to working with the team to build DecisionView into a large, profitable business.”

While at Siebel Systems, Andrade was recognized for leading the company's life sciences business through a period of significant growth, including global expansion and the development and commercialization of sales, marketing, service and clinical trial management software solutions. Additionally, he has held numerous management positions at market-leading companies, including IMS Health, Eli Lilly and Company and various clinical research ventures prior to his tenure at Oracle and Siebel Systems. “From the beginning, DecisionView has focused exclusively on performance optimization solutions for the Global Life Sciences industry,” said Jack Porter, who Andrade replaces as CEO. “With Steve's background and general management expertise, he is the perfect addition to the team at a time when DecisionView is experiencing rapid growth.”

“Steve understands the needs of pharmaceutical and medical products companies and knows how to integrate software to improve operating performance” said Thomas McKinley, managing partner and co-founder of Partech International and DecisionView board member.

Chris Hollenbeck, managing director at Granite Ventures and also a DecisionView board member added, “Steve took Siebel Life Sciences from an early growth stage to the dominant market leader in the industry. We think he has a similar opportunity with DecisionView and look forward to working with him to realize the Company's potential.”

About DecisionView
Founded in 2003, DecisionView Software Inc., provides performance optimization solutions to the world's leading Life Sciences companies. The Company's flagship product suite, StudyManager, enables pharmaceutical and biotech companies to make critical business decisions and improve performance in the clinical phase of drug development. For more information, please visit www.decisionviewsoftware.com.

###